Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTP4A1 | Q93096 | 3/20 | 0.46 |
| ▸ | PTP4A3 | O75365 | 2/20 | 0.46 |
| ▸ | PTP4A2 | Q12974 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | NPC1 | O15118 | 4/20 | 0.40 |
| ▸ | RAB9A | P51151 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7482640 | 0.82 | PTP4A1 (0.43) | PTP4A1PTP4A3PTP4A2CYP2C9MAPT | |
| SCHEMBL7482643 | 0.82 | PTP4A1 (0.43) | PTP4A1PTP4A3PTP4A2CYP2C9MAPT | |
| SCHEMBL11269373 | 0.82 | CYP2C9 (0.62) | PTP4A1CYP2C9MAPTNPC1RAB9A | |
| SCHEMBL167038 | 0.82 | CYP2C9 (0.62) | PTP4A1CYP2C9MAPTNPC1RAB9A | |
| SCHEMBL6293723 | 0.80 | PTP4A1 (0.49) | PTP4A1PTP4A3PTP4A2CYP2C9MAPT | |
| SCHEMBL1566520 | 0.80 | CYP2C9 (0.45) | PTP4A1PTP4A3PTP4A2CYP2C9MAPT | |
| SCHEMBL1566521 | 0.80 | CYP2C9 (0.45) | PTP4A1PTP4A3PTP4A2CYP2C9MAPT | |
| SCHEMBL4088999 | 0.80 | CYP2C9 (0.45) | PTP4A1PTP4A3PTP4A2CYP2C9MAPT | |
| SCHEMBL7117459 | 0.79 | PTP4A3 (0.48) | PTP4A1PTP4A3PTP4A2CYP2C9MAPT | |
| SCHEMBL7117452 | 0.79 | PTP4A3 (0.48) | PTP4A1PTP4A3PTP4A2CYP2C9MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2089308-B1 | DISPENSER | ETHICON INC (US) | 2018-12-26 | — | — | EP | disclosed |
| CN-105980511-A | Screen frame configuration and screen device | 日立化成株式会社 | 2016-09-28 | — | — | CN | disclosed |
| US-8287202-B2 | Method for dispensing a polymerizable monomer adhesive | ETHICON, INC. (US) | 2012-10-16 | — | — | US | disclosed |
| US-20120160867-A1 | DISPENSER WITH A FRANGIBLE CONTAINER AND A ROTATING BREAKING MEMBER, FOR DISPENSING A POLYMERIZABLE MONOMER ADHESIVE | CLOSURE MEDICAL CORPORATION | 2012-06-28 | — | — | US | disclosed |
| US-8118508-B2 | Dispenser with a frangible container and a rotating breaking member, for dispensing a polymerizable monomer adhesive | CLOSURE MEDICAL CORPORATION (US) | 2012-02-21 | — | — | US | disclosed |
| EP-2413943-A1 | CONTROLLED EXOTHERM OF CYANOACRYLATE FORMULATIONS | Ethicon, Inc (US) | 2012-02-08 | — | — | EP | disclosed |
| US-7932305-B2 | Viscous α-cyanoacrylate compositions | ETHICON, INC. (US) | 2011-04-26 | — | — | US | disclosed |
| US-20100269749-A1 | Absorbable Cyanoacrylate Compositions | ETHICON, INC. | 2010-10-28 | — | — | US | disclosed |
| WO-2010114779-A1 | CONTROLLED EXOTHERM OF CYANOACRYLATE FORMULATIONS | ETHICON, INC. (US) | 2010-10-07 | — | — | WO | disclosed |
| US-20100249698-A1 | CONTROLLED EXOTHERM OF CYANOACRYLATE FORMULATIONS | ETHICON, INC. | 2010-09-30 | — | — | US | disclosed |
| WO-2009158302-A2 | VISCOUS ALPHA-CYANOACRYLATE COMPOSITIONS | CLOSURE MEDICAL CORPORATION (US) | 2009-12-30 | — | — | WO | disclosed |
| EP-2089308-A2 | DISPENSER | Closure Medical Corporation (US) | 2009-08-19 | — | — | EP | disclosed |
| US-20080241249-A1 | Cyanoacrylate composite | CLOSURE MEDICAL CORPORATION (US) | 2008-10-02 | — | — | US | disclosed |
| EP-1928920-A2 | IMPROVED STABILIZER CYANOACRYLATE FORMULATIONS | Closure Medical Corporation (US) | 2008-06-11 | — | — | EP | disclosed |
| WO-2008067220-A2 | DISPENSER | CLOSURE MEDICAL CORPORATION (US) | 2008-06-05 | — | — | WO | disclosed |
| US-20080131190-A1 | Dispenser | ETHICON, INC. | 2008-06-05 | — | — | US | disclosed |
| WO-2008005634-A1 | ABSORBABLE CYANOACRYLATE COMPOSITIONS | CLOSURE MEDICAL CORPORATION (US) | 2008-01-10 | — | — | WO | disclosed |
| US-20080003196-A1 | Absorbable cyanoacrylate compositions | ETHICON, INC. | 2008-01-03 | — | — | US | disclosed |
| WO-2007041143-A2 | IMPROVED STABILIZER CYANOACRYLATE FORMULATIONS | CLOSURE MEDICAL CORPORATION (US) | 2007-04-12 | — | — | WO | disclosed |
| US-20070078207-A1 | Stabilizer cyanoacrylate formulations | ETHICON, INC. | 2007-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080241249-A1 | Cyanoacrylate composite | ALOX5, SCD, SCD5 | PTP4A1 2061/4885PTP4A3 2475/4885PTP4A2 3161/4885 |
| US-20080003196-A1 | Absorbable cyanoacrylate compositions | PCNA, FGB, F13A1 | PTP4A1 4621/4885PTP4A3 4752/4885PTP4A2 4774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.